Immune response after one or two doses of pandemic influenza A (H1N1) monovalent, AS03-adjuvanted vaccine in HIV infected adults.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Continued research is needed to evaluate and improve the immunogenicity of influenza vaccines in HIV infected patients. We aimed to determine the antibody responses after one or two doses of the AS03-adjuvanted pandemic influenza A (H1N1) vaccine in HIV infected patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Vaccine

Title: Vaccine

Publisher: Elsevier BV

ISSN (Electronic): 1873-2518

ISSN (Print): 0264-410X

Publication date (Electronic): Nov 19 2012

Volume: 30

Issue: 49

Affiliations

[1 ] Department for Infectious Diseases, Hvidovre Hospital, University Hospital of Copenhagen, Copenhagen, Denmark. allan@bybeck.dk

Article

Publisher Item ID: S0264-410X(12)01372-2

DOI: 10.1016/j.vaccine.2012.09.052

PubMed ID: 23036498

SO-VID: 3de32a6c-3efe-4738-adf0-9e20d12cc36c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by